LCI-5.32 06/06/2011 - Lannett Announces Revised FDA PDUFA Date For Morphine Sulfate Oral Solution NDA Lannett Company, Inc. (NYSE AMEX:LCI) announced today that the U.S.Food and Drug Administration (FDA) has issued a revised Prescription Drug User Fee Act (PDUFA) goal date of June 23, 2011 for the company's 505(b)(2) New Drug Application for Morphine Sulfate Oral Solution.